Hernia, HiatalPhase 3LARGENCT01408108
Laparoscopic Lightweight Mesh Repair of Large Hiatal Hernias
A Phase 3 study testing Laparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh and Laparoscopic primary posterior crural repair in people with Hernia, Hiatal, run by Odessa National Medical University at 1 site in Ukraine.
Trial summary
This study is prospective randomized trial enrolling at least 100 participants which compares efficacy and safety of two alternative methods of laparoscopic hiatal repair for large (i.e. Read more about this study
- Who is it for?
- Ages 20 to 80 years
- Conditions the study is for
- Hernia, Hiatal
- What is being tested?
- Laparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh and Laparoscopic primary posterior crural repair
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUkraine
- Study dates
- Jan 2013to Jul 2016
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Type I, II and III hiatal hernias, including complicated by GERD
- Able to undergo elective laparoscopic hiatal hernia repair
- Able to 24 months follow-up with office examinations
- Hiatal surface area (HSA) measuring 10 to 20 sq.cm (by granderath et al, 2007) which correspond to the diameter of hernia defect measuring 5 to 8 cm (the distinct size is determined intraoperatively, those with smaller or larger diameter will be excluded from the study)
Who cannot join
- Unable to undergo laparoscopic hiatal hernia repair due to: severe comorbidities (ASA III and more), previous major surgery with severe adhesions, etc.
- Cases of conversion to open surgery
- Age < 20 years and > 80 years
- BMI < 16 and > 39 kg/m2
- Pregnancy or plans for pregnancy within next 2 years (in females)
- Uncorrectable coagulopathy and immunosuppression
Show all 13Show fewer
- Oesophageal motility disorders
- Oesophageal peptic strictures
- Oesophageal diverticula, other types (i.e. non-reflux) of chronic esophagitis, connective tissue disorders (e.g. scleroderma)
- Oesophageal shortening (determined intraoperatively as inability to achieve intra-abdominal length of oesophagus at least 3 cm in spite of intramediastinal oesophageal mobilization)
- Barrett's oesophagus
- History of oesophageal/gastric/duodenal surgery including vagotomy
- Relapsing course of ulcer disease/hyperacid gastritis including complicated by delayed gastric/duodenal emptying
Trial locations and contacts
1 site in 1 country.
Ukraine1 site
Department of surgery # 1 of Odessa national medical university, Odessa regional hospital
Odesa, 65025
About this study
Official title: Prospective Randomized Phase III Study of Laparoscopic Lightweight Mesh Repair of Large Hiatal Hernias
This study is prospective randomized trial enrolling at least 100 participants which compares efficacy and safety of two alternative methods of laparoscopic hiatal repair for large (i.e. with hiatal surface area (HSA) ranging from 10 to 20 sq.cm, which corresponds to diameter of defect from 5 to 8 cm) types I, II, and III hiatal hernias: primary crural repair and repair with partially absorbable lightweight mesh. According to the literature, rates of anatomical failure and recurrence of GERD after primary repair of large hiatal hernias reach 42 %. Mesh repair decreases rates of failures, however, polypropylene and composite PTFE meshes used most widely, result in unacceptable rates of long-term dysphagia and oesophageal strictures. Our own experience of more than 400 repairs using partially absorbable lightweight mesh Ultrapro (Ethicon) and original sub-lay technique of its fixation precluding contact of the mesh with the oesophagus, showed low recurrence rate and a few cases of long-term dysphagia. Thus, final conclusions could be established by prospective randomized study. Our hypothesis is: original technique of lightweight mesh repair is highly effective for prevention of recurrences compared to primary repair and safe in terms of mesh-related dysphagia and oesophageal strictures. The long-term results (24 months post surgery for every patient) will be studied using symptom questionnaires, quality of life and satisfaction questionnaires, barium studies, endoscopic examinations, 24-hour pH testing, and analysis of possible reoperations.
Read the detailed description
Methods of laparoscopic repair of large and giant hiatal hernias are the most challenging questions in gastrointestinal minimally invasive surgery. The literature demonstrates high rates of anatomical and functional recurrence after laparoscopic repair of large hiatal hernias, particularly following primary crural repair. Different methods of mesh repair were introduced and several trials showed their benefits. However, necessity and method of prosthetic repair remain questionable as mesh repair results in high frequency of long-term dysphagia and oesophageal strictures.
There is insufficient grade 1 evidence for choice of optimal method of repair of large hiatal hernias. Only 3 prospective randomized trials comparing prosthetic and primary hiatal repair were published by Frantzides et al (2002), Granderath et al (2005), and Oelschlager et al (2006). However, these trials could not recommend effective, safe, and relatively inexpensive method of repair. Although Frantzides et al (2002) showed statistically significant decrease of recurrence rate in composite (ePTFE) mesh arm, the study included only patients with diameter of defect 8 cm and greater, thus it is still unknown whether mesh should be used for hernias with smaller diameter of hernia defect, for example, between 5 and 8 cm. Most specialists use mesh when the diameter of the defect is just greater than 5 cm, based on their own experience and widespread literature data, including studies of Champion et al (1998, 2003). In addition, hiatal surface area (HSA), first described by Granderath et al (2007), is more sensitive measure than diameter of hiatal hernia defect, and further trials should focus on it. Finally, ePTFE prosthesis is rather expensive.
The trial of Granderath et al (2005) also was not primarily focused of relation between diameter of hernia defect and rate of recurrences. In this study, recurrence rate was also smaller in the polypropylene arm, but the rate of dysphagia was lager in the same arm. Although later these authors reported that differences between arms in rates of dysphagia and motility disorders vanished in 1 year, most of authors still consider polypropylene mesh potentially unsafe (Frantzides et al, 2010).
To remove the risk of mesh-related oesophageal complications, biological prostheses were introduced for hiatal repair, but the study of Oelschlager et al (2006) demonstrated insignificant difference in recurrence rates in prosthesis arm compared to primary repair arm, although no cases of mesh-related complications were observed in prosthesis arm. Data from the literature and international congresses suggest that biological devices cannot be widely used in the setting of large hiatal hernias due to high rate of recurrences and their high price. Data from another recent numerous publications including reviews made the same conclusions that large and giant hiatal hernias require mesh repair but search for the optimal prosthesis and fashion of its fixation is ongoing.
Hiatal repair by partially absorbable lightweight meshes is promising technique and may become an optimal because it can minimize both recurrences and oesophageal complications. Hazebroek et al (2008) reported good functional, endoscopic, and radiological outcomes in terms of esophageal complications after on-lay placement of titanium-coated lightweight polypropylene mesh (non-randomized prospective study). Our own experience of 400 repairs using lightweight mesh (Ultrapro, Ethicon) and original sub-lay technique of its fixation precluding contact of the mesh with the oesophagus, showed low recurrence rate (4,9%) and a few cases of long-term dysphagia (2,1%). Therefore, the hypothesis of our double-blind prospective randomized trial is: original technique of lightweight mesh (Ultrapro, Ethicon) repair is highly effective for prevention of recurrences compared to primary repair and safe in terms of mesh-related dysphagia and oesophageal strictures.
The study will enroll at least 100 patients with large (i.e. with hiatal surface area (HSA) ranging from 10 to 20 sq.cm, which corresponds to diameter of defect from 5 to 8 cm) types I, II, and III hiatal hernias. The chosen size of the defect is the most questionable in terms of the need for applying a mesh: when HSA is 20 sq.cm or greater the necessity of mesh repair is obvious, when it is less than 10 sq.cm usage of mesh is unreasonable. The basic eligibility criteria will be: absence of oesophageal motility disorders, absence of oesophageal shortening requiring Collis procedure, absence of peptic strictures and other factors that may independently influence the rate of recurrence and dysphagia/oesophageal strictures. Thus, the only difference between arms will be method of hiatal closure. To exclude fundoplication-related bias, standard floppy-Nissen procedure will be performed in every patient.
Every patient will be operated by single surgical team with an experience of more than 1500 laparoscopic anti-reflux procedures since 1998. The necessary ethic regulations will be saved including informed consent with the statement that patient is unaware of the method of repair (double-masked). Every patient is going to be evaluated preoperatively, 6 months, and 24 months postoperatively using symptom questionnaires, quality of life and satisfaction questionnaires, barium studies, endoscopic examinations, and 24-hour pH testing. For issue of efficacy of prosthetic repair, recurrence rate of hernia and GERD, which are the primary outcome measure, will be studied. For issue of safety of prosthetic repair, rates of short- and long-term dysphagia/oesophageal strictures/mesh erosions, which are main secondary outcome measure, will be evaluated.
- Conditions
- Hernia, Hiatal
- Being tested
- Laparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh, Laparoscopic primary posterior crural repair
- Keywords
- Hiatal hernia, Gastro-oesophageal reflux disease, Laparoscopic hiatal repair, Laparoscopic anti-reflux surgery, Partially absorbable lightweight mesh
- Medical subject headings
- Hernia, Hiatal, Gastroesophageal Reflux
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Laparoscopic hiatal repair with sub-lay partially absorbable lightweight meshProcedure or surgery
Also called Laparoscopic mesh hiatoplasty, Laparoscopic mesh hiatal closure
A fashioned according to the dimensions of hernia defect partially absorbable lightweight mesh Ultrapro™ (Ethicon, Inc.) will be sutured to both crura with 3 to 5 interrupted non-absorbable (Ethibond™ 3-0 by Ethicon, Inc.) sutures (as tension-free repair). Subsequent 2 to 3 interrupted non-absorbable sutures will approximate crura to completely cover a mesh to preclude its contact with the esophagus (original "sandwich" sub-lay technique).
Laparoscopic primary posterior crural repairProcedure or surgery
Also called Laparoscopic posterior crurorrhaphy, Laparoscopic posterior crural closure
Posterior cruroraphy will be performed with 3 to 4 interrupted non-absorbable (Ethibond™ 3-0 by Ethicon, Inc.) sutures.
In the both arms laparoscopic procedure will be done in a standard fashion: reduction of hernia with excision of hernia sac and mobilization of distal esophagus, exposure of borders of hiatal opening including crura posteriorly to esophagus, repair if hiatal hernia defect (30 Fr esophageal bougie is used), a short (2,5 - 3,5 cm) 360° fundoplication wrap (floppy-Nissen procedure) (30 Fr esophageal bougie is used).
| Study group | Role | What they receive |
|---|---|---|
| Lightweight mesh repair | Active comparator | Laparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh Receives: Procedure: Laparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh |
| Primary crural repair | Active comparator | Laparoscopic primary posterior crural repair Receives: Procedure: Laparoscopic primary posterior crural repair |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anatomical and functional recurrence of hiatal hernia and GERD
Recurrence of hiatal hernia, i.e. anatomical recurrence, will be assessed by symptom questionnaire with visual analogue scales, MAINLY by barium study, and data from possible redo procedures. Recurrence of GERD, i.e. functional recurrence, will be evaluated by symptom questionnaire with visual analogue scales, endoscopic examination with assessment of degree of reflux-oesophagitis according to Los-Angeles classification, and 24 hour pH-testing with calculation of DeMeester score.
Measured: 24 months
Secondary outcomes (6)
Repair-related dysphagia/oesophageal stricture/prosthetic erosion
Short- and long-term dysphagia, including due to repair-related oesophageal stricture, will be assessed by symptom questionnaire with visual analogue scales, barium study, endoscopic examination, and data from possible redo procedures. Patients also will be endoscopically assessed for such rare complication as prosthetic erosion of oesophagus.
Measured: 24 months
Quality of life and satisfaction
Quality of life and satisfaction will be assessed by GERD-HRQL score
Measured: 24 months
Operative time
Measured: 1 day
Morbidity
Measured: 1 month
Postoperative hospital stay
Measured: 1 month
Influence on extra-oesophageal complications
Extra-oesophageal complications to be assessed are: asthma, COPD, laryngitis, angina, and arrhythmias
Measured: 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Aug 2011 (estimated)
- Study startJan 2013
- Primary completionJul 2014
- Study completionJul 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Hernia, HiatalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Odessa National Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr. Andriy V. Malynovskyy, Odessa National Medical University
- Investigators
- Volodymyr V. Grubnik, Prof., MD, Principal investigator, Department of surgery # 1 of Odessa national medical university
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01408108
- Sponsor's protocol ID
- ONMU-1
- Acronym
- LARGE
- Status last verified
- Oct 2015
- First submitted
- 1 Aug 2011
- Last updated
- 14 Oct 2015
- Results posted
- No
- Data monitoring committee
- No
Publications
Frantzides CT, Madan AK, Carlson MA, Stavropoulos GP. A prospective, randomized trial of laparoscopic polytetrafluoroethylene (PTFE) patch repair vs simple cruroplasty for large hiatal hernia. Arch Surg. 2002 Jun;137(6):649-52. doi: 10.1001/archsurg.137.6.649.
PubMed 12049534Granderath FA, Schweiger UM, Kamolz T, Asche KU, Pointner R. Laparoscopic Nissen fundoplication with prosthetic hiatal closure reduces postoperative intrathoracic wrap herniation: preliminary results of a prospective randomized functional and clinical study. Arch Surg. 2005 Jan;140(1):40-8. doi: 10.1001/archsurg.140.1.40.
PubMed 15655204Oelschlager BK, Pellegrini CA, Hunter JG, Brunt ML, Soper NJ, Sheppard BC, Polissar NL, Neradilek MB, Mitsumori LM, Rohrmann CA, Swanstrom LL. Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial. J Am Coll Surg. 2011 Oct;213(4):461-8. doi: 10.1016/j.jamcollsurg.2011.05.017. Epub 2011 Jun 29.
PubMed 21715189Champion JK, McKernan JB. Hiatal size and risk of recurrence after laparoscopic fundoplication [abstract]. Surg Endosc. 1998; 12:565-570.
Champion JK, Rock D. Laparoscopic mesh cruroplasty for large paraesophageal hernias. Surg Endosc. 2003 Apr;17(4):551-3. doi: 10.1007/s00464-002-8817-7. Epub 2003 Feb 17.
PubMed 12582773Frantzides CT, Carlson MA, Loizides S, Papafili A, Luu M, Roberts J, Zeni T, Frantzides A. Hiatal hernia repair with mesh: a survey of SAGES members. Surg Endosc. 2010 May;24(5):1017-24. doi: 10.1007/s00464-009-0718-6. Epub 2009 Dec 8.
PubMed 19997755Hazebroek EJ, Ng A, Yong DH, Berry H, Leibman S, Smith GS. Evaluation of lightweight titanium-coated polypropylene mesh (TiMesh) for laparoscopic repair of large hiatal hernias. Surg Endosc. 2008 Nov;22(11):2428-32. doi: 10.1007/s00464-008-0070-2. Epub 2008 Jul 15.
PubMed 18626699Granderath FA, Schweiger UM, Pointner R. Laparoscopic antireflux surgery: tailoring the hiatal closure to the size of hiatal surface area. Surg Endosc. 2007 Apr;21(4):542-8. doi: 10.1007/s00464-006-9041-7. Epub 2006 Nov 14.
PubMed 17103275Grubnik VV, Malynovskyy AV. Laparoscopic repair of hiatal hernias: new classification supported by long-term results. Surg Endosc. 2013 Nov;27(11):4337-46. doi: 10.1007/s00464-013-3069-2. Epub 2013 Jul 23.
PubMed 23877759
Study at a glance
From the registry record, last updated by the sponsor on 14 Oct 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective Randomized Phase III Study of Laparoscopic Lightweight Mesh Repair of Large Hiatal Hernias
- ClinicalTrials.gov ID
- NCT01408108
- Acronym / sponsor ID
- LARGE / ONMU-1
- Conditions
- Hernia, Hiatal
- Keywords
- Hiatal hernia, Gastro-oesophageal reflux disease, Laparoscopic hiatal repair, Laparoscopic anti-reflux surgery, Partially absorbable lightweight mesh
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Odessa National Medical UniversityUniversity, hospital or other
- Study start
- Jan 2013
- Primary completion
- Jul 2014 (actual)
- Study completion
- Jul 2016 (estimated)
- First posted
- 3 Aug 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is prospective randomized trial enrolling at least 100 participants which compares efficacy and safety of two alternative methods of laparoscopic hiatal repair for large (i.e. with hiatal surface area (HSA) ranging from 10 to 20 sq.cm, which corresponds to diameter of defect from 5 to 8 cm) types I, II, and III hiatal hernias: primary crural repair and repair with partially absorbable lightweight mesh. According to the literature, rates of anatomical failure and recurrence of GERD after primary repair of large hiatal hernias reach 42 %. Mesh repair decreases rates of failures, however, polypropylene and composite PTFE meshes used most widely, result in unacceptable rates of long-term dysphagia and oesophageal strictures. Our own experience of more than 400 repairs using partially absorbable lightweight mesh Ultrapro (Ethicon) and original sub-lay technique of its fixation precluding contact of the mesh with the oesophagus, showed low recurrence rate and a few cases of long-term dysphagia. Thus, final conclusions could be established by prospective randomized study. Our hypothesis is: original technique of lightweight mesh repair is highly effective for prevention of recurrences compared to primary repair and safe in terms of mesh-related dysphagia and oesophageal strictures. The long-term results (24 months post surgery for every patient) will be studied using symptom questionnaires, quality of life and satisfaction questionnaires, barium studies, endoscopic examinations, 24-hour pH testing, and analysis of possible reoperations.
Detailed description
Methods of laparoscopic repair of large and giant hiatal hernias are the most challenging questions in gastrointestinal minimally invasive surgery. The literature demonstrates high rates of anatomical and functional recurrence after laparoscopic repair of large hiatal hernias, particularly following primary crural repair. Different methods of mesh repair were introduced and several trials showed their benefits. However, necessity and method of prosthetic repair remain questionable as mesh repair results in high frequency of long-term dysphagia and oesophageal strictures.
There is insufficient grade 1 evidence for choice of optimal method of repair of large hiatal hernias. Only 3 prospective randomized trials comparing prosthetic and primary hiatal repair were published by Frantzides et al (2002), Granderath et al (2005), and Oelschlager et al (2006). However, these trials could not recommend effective, safe, and relatively inexpensive method of repair. Although Frantzides et al (2002) showed statistically significant decrease of recurrence rate in composite (ePTFE) mesh arm, the study included only patients with diameter of defect 8 cm and greater, thus it is still unknown whether mesh should be used for hernias with smaller diameter of hernia defect, for example, between 5 and 8 cm. Most specialists use mesh when the diameter of the defect is just greater than 5 cm, based on their own experience and widespread literature data, including studies of Champion et al (1998, 2003). In addition, hiatal surface area (HSA), first described by Granderath et al (2007), is more sensitive measure than diameter of hiatal hernia defect, and further trials should focus on it. Finally, ePTFE prosthesis is rather expensive.
The trial of Granderath et al (2005) also was not primarily focused of relation between diameter of hernia defect and rate of recurrences. In this study, recurrence rate was also smaller in the polypropylene arm, but the rate of dysphagia was lager in the same arm. Although later these authors reported that differences between arms in rates of dysphagia and motility disorders vanished in 1 year, most of authors still consider polypropylene mesh potentially unsafe (Frantzides et al, 2010).
To remove the risk of mesh-related oesophageal complications, biological prostheses were introduced for hiatal repair, but the study of Oelschlager et al (2006) demonstrated insignificant difference in recurrence rates in prosthesis arm compared to primary repair arm, although no cases of mesh-related complications were observed in prosthesis arm. Data from the literature and international congresses suggest that biological devices cannot be widely used in the setting of large hiatal hernias due to high rate of recurrences and their high price. Data from another recent numerous publications including reviews made the same conclusions that large and giant hiatal hernias require mesh repair but search for the optimal prosthesis and fashion of its fixation is ongoing.
Hiatal repair by partially absorbable lightweight meshes is promising technique and may become an optimal because it can minimize both recurrences and oesophageal complications. Hazebroek et al (2008) reported good functional, endoscopic, and radiological outcomes in terms of esophageal complications after on-lay placement of titanium-coated lightweight polypropylene mesh (non-randomized prospective study). Our own experience of 400 repairs using lightweight mesh (Ultrapro, Ethicon) and original sub-lay technique of its fixation precluding contact of the mesh with the oesophagus, showed low recurrence rate (4,9%) and a few cases of long-term dysphagia (2,1%). Therefore, the hypothesis of our double-blind prospective randomized trial is: original technique of lightweight mesh (Ultrapro, Ethicon) repair is highly effective for prevention of recurrences compared to primary repair and safe in terms of mesh-related dysphagia and oesophageal strictures.
The study will enroll at least 100 patients with large (i.e. with hiatal surface area (HSA) ranging from 10 to 20 sq.cm, which corresponds to diameter of defect from 5 to 8 cm) types I, II, and III hiatal hernias. The chosen size of the defect is the most questionable in terms of the need for applying a mesh: when HSA is 20 sq.cm or greater the necessity of mesh repair is obvious, when it is less than 10 sq.cm usage of mesh is unreasonable. The basic eligibility criteria will be: absence of oesophageal motility disorders, absence of oesophageal shortening requiring Collis procedure, absence of peptic strictures and other factors that may independently influence the rate of recurrence and dysphagia/oesophageal strictures. Thus, the only difference between arms will be method of hiatal closure. To exclude fundoplication-related bias, standard floppy-Nissen procedure will be performed in every patient.
Every patient will be operated by single surgical team with an experience of more than 1500 laparoscopic anti-reflux procedures since 1998. The necessary ethic regulations will be saved including informed consent with the statement that patient is unaware of the method of repair (double-masked). Every patient is going to be evaluated preoperatively, 6 months, and 24 months postoperatively using symptom questionnaires, quality of life and satisfaction questionnaires, barium studies, endoscopic examinations, and 24-hour pH testing. For issue of efficacy of prosthetic repair, recurrence rate of hernia and GERD, which are the primary outcome measure, will be studied. For issue of safety of prosthetic repair, rates of short- and long-term dysphagia/oesophageal strictures/mesh erosions, which are main secondary outcome measure, will be evaluated.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Lightweight mesh repair | Active comparator | Procedure: Laparoscopic hiatal repair with sub-lay partially absorbable lightweight meshLaparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh |
| Primary crural repair | Active comparator | Procedure: Laparoscopic primary posterior crural repairLaparoscopic primary posterior crural repair |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Type I, II and III hiatal hernias, including complicated by GERD
- Able to undergo elective laparoscopic hiatal hernia repair
- Able to 24 months follow-up with office examinations
- Hiatal surface area (HSA) measuring 10 to 20 sq.cm (by granderath et al, 2007) which correspond to the diameter of hernia defect measuring 5 to 8 cm (the distinct size is determined intraoperatively, those with smaller or larger diameter will be excluded from the study)
Key exclusion criteria (13 listed)
- Unable to undergo laparoscopic hiatal hernia repair due to: severe comorbidities (ASA III and more), previous major surgery with severe adhesions, etc.
- Cases of conversion to open surgery
- Age < 20 years and > 80 years
- BMI < 16 and > 39 kg/m2
- Pregnancy or plans for pregnancy within next 2 years (in females)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Laparoscopic hiatal repair with sub-lay partially absorbable lightweight meshAlso: Laparoscopic mesh hiatoplasty, Laparoscopic mesh hiatal closureA fashioned according to the dimensions of hernia defect partially absorbable lightweight mesh Ultrapro™ (Ethicon, Inc.) will be sutured to both crura with 3 to 5 interrupted non-absorbable (Ethibond™ 3-0 by Ethicon, Inc.) sutures (as tension-free repair). Subsequent 2 to 3 interrupted non-absorbable sutures will approximate crura to completely cover a mesh to preclude its contact with the esophagus (original "sandwich" sub-lay technique). | Procedure or surgery | Lightweight mesh repair |
| Laparoscopic primary posterior crural repairAlso: Laparoscopic posterior crurorrhaphy, Laparoscopic posterior crural closurePosterior cruroraphy will be performed with 3 to 4 interrupted non-absorbable (Ethibond™ 3-0 by Ethicon, Inc.) sutures. In the both arms laparoscopic procedure will be done in a standard fashion: reduction of hernia with excision of hernia sac and mobilization of distal esophagus, exposure of borders of hiatal opening including crura posteriorly to esophagus, repair if hiatal hernia defect (30 Fr esophageal bougie is used), a short (2,5 - 3,5 cm) 360° fundoplication wrap (floppy-Nissen procedure) (30 Fr esophageal bougie is used). | Procedure or surgery | Primary crural repair |
Primary outcome
Anatomical and functional recurrence of hiatal hernia and GERD
Time frame: 24 months
Recurrence of hiatal hernia, i.e. anatomical recurrence, will be assessed by symptom questionnaire with visual analogue scales, MAINLY by barium study, and data from possible redo procedures. Recurrence of GERD, i.e. functional recurrence, will be evaluated by symptom questionnaire with visual analogue scales, endoscopic examination with assessment of degree of reflux-oesophagitis according to Los-Angeles classification, and 24 hour pH-testing with calculation of DeMeester score.
6 secondary outcomes
Repair-related dysphagia/oesophageal stricture/prosthetic erosion
Time frame: 24 months
Quality of life and satisfaction
Time frame: 24 months
Operative time
Time frame: 1 day
Morbidity
Time frame: 1 month
Postoperative hospital stay
Time frame: 1 month
Influence on extra-oesophageal complications
Time frame: 24 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Oct 2015.
- Background: PubMed 12049534Frantzides CT, Madan AK, Carlson MA, Stavropoulos GP. A prospective, randomized trial of laparoscopic polytetrafluoroethylene (PTFE) patch repair vs simple cruroplasty for large hiatal hernia. Arch Surg. 2002 Jun;137(6):649-52. doi: 10.1001/archsurg.137.6.649.
- Background: PubMed 15655204Granderath FA, Schweiger UM, Kamolz T, Asche KU, Pointner R. Laparoscopic Nissen fundoplication with prosthetic hiatal closure reduces postoperative intrathoracic wrap herniation: preliminary results of a prospective randomized functional and clinical study. Arch Surg. 2005 Jan;140(1):40-8. doi: 10.1001/archsurg.140.1.40.
- Background: PubMed 21715189Oelschlager BK, Pellegrini CA, Hunter JG, Brunt ML, Soper NJ, Sheppard BC, Polissar NL, Neradilek MB, Mitsumori LM, Rohrmann CA, Swanstrom LL. Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial. J Am Coll Surg. 2011 Oct;213(4):461-8. doi: 10.1016/j.jamcollsurg.2011.05.017. Epub 2011 Jun 29.
- BackgroundChampion JK, McKernan JB. Hiatal size and risk of recurrence after laparoscopic fundoplication [abstract]. Surg Endosc. 1998; 12:565-570.
- Background: PubMed 12582773Champion JK, Rock D. Laparoscopic mesh cruroplasty for large paraesophageal hernias. Surg Endosc. 2003 Apr;17(4):551-3. doi: 10.1007/s00464-002-8817-7. Epub 2003 Feb 17.
- Background: PubMed 19997755Frantzides CT, Carlson MA, Loizides S, Papafili A, Luu M, Roberts J, Zeni T, Frantzides A. Hiatal hernia repair with mesh: a survey of SAGES members. Surg Endosc. 2010 May;24(5):1017-24. doi: 10.1007/s00464-009-0718-6. Epub 2009 Dec 8.
- Background: PubMed 18626699Hazebroek EJ, Ng A, Yong DH, Berry H, Leibman S, Smith GS. Evaluation of lightweight titanium-coated polypropylene mesh (TiMesh) for laparoscopic repair of large hiatal hernias. Surg Endosc. 2008 Nov;22(11):2428-32. doi: 10.1007/s00464-008-0070-2. Epub 2008 Jul 15.
- Background: PubMed 17103275Granderath FA, Schweiger UM, Pointner R. Laparoscopic antireflux surgery: tailoring the hiatal closure to the size of hiatal surface area. Surg Endosc. 2007 Apr;21(4):542-8. doi: 10.1007/s00464-006-9041-7. Epub 2006 Nov 14.
- Background: PubMed 23877759Grubnik VV, Malynovskyy AV. Laparoscopic repair of hiatal hernias: new classification supported by long-term results. Surg Endosc. 2013 Nov;27(11):4337-46. doi: 10.1007/s00464-013-3069-2. Epub 2013 Jul 23.
Related trials for Hernia, Hiatal
Recruiting
GORE® ENFORM Biomaterial Product Study
Hernia, Ventral, Hernia, Hiatal
Active, not recruiting
Gastropexy in the Repair of Patients With Paraesophageal Hernias
Paraesophageal Hernia
Recruiting
Mesh Vs Pledgets for Repair of Paraesophageal Hernia
Paraesophageal Hernia, GERD
Recruiting
Phrenoesophageal Ligament Reconstruction With Mesh
Hiatus Hernia, Gastreoesophageal Reflux Disease
RecruitingObservational study
Preoperative Predictors of Symptom Improvement After Laparoscopic Fundoplication
Gastroesophageal Reflux Disease, Hiatal Hernia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Volodymyr V. Grubnik, Prof., MD principal investigator
Department of surgery # 1 of Odessa national medical university
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Laparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh and Laparoscopic primary posterior crural repair in people with Hernia, Hiatal, run by Odessa National Medical University at 1 site in Ukraine.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ukraine. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anatomical and functional recurrence of hiatal hernia and GERD (time frame: 24 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01408108, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2015.